TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/5/24 17:48 | 4/3/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kohli Aditya | MA | D | S.m | -264 | 14.69 | 0 | -18 | -2 | 790 | D | |||||||||||||||
3/20/24 18:27 | 3/18/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kohli Aditya | MA | D | S.em | -375 | 20.81 | 0 | -18 | -2 | 808 | D | |||||||||||||||
3/8/24 18:38 | 3/6/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kohli Aditya | MA | D | S.m | -336 | 18.66 | 0 | -18 | -2 | 826 | D | |||||||||||||||
2/22/24 17:20 | 2/20/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kohli Aditya | MA | D | S.m | -269 | 14.95 | 0 | -18 | -2 | 844 | D | |||||||||||||||
2/14/24 16:22 | 2/12/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kohli Aditya | MA | D | S | -92 | 15.32 | 0 | -6 | -1 | 862 | D | |||||||||||||||
2/12/24 20:06 | 2/8/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kohli Aditya | MA | D | S.d | -132 | 14.93 | 0 | -9 | -1 | 868 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |